NM_001127644.2:c.85C>T

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2

The NM_001127644.2(GABRA1):​c.85C>T​(p.Pro29Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000196 in 1,584,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P29L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000084 ( 0 hom. )

Consequence

GABRA1
NM_001127644.2 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 4.14

Publications

4 publications found
Variant links:
Genes affected
GABRA1 (HGNC:4075): (gamma-aminobutyric acid type A receptor subunit alpha1) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene cause juvenile myoclonic epilepsy and childhood absence epilepsy type 4. Multiple transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008]
GABRA1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 19
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, idiopathic generalized, susceptibility to, 13
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PM1
In a topological_domain Extracellular (size 225) in uniprot entity GBRA1_HUMAN there are 33 pathogenic changes around while only 10 benign (77%) in NM_001127644.2
BP4
Computational evidence support a benign effect (MetaRNN=0.04846707).
BP6
Variant 5-161854168-C-T is Benign according to our data. Variant chr5-161854168-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 197167.
BS2
High AC in GnomAd4 at 19 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127644.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA1
NM_001127644.2
MANE Select
c.85C>Tp.Pro29Ser
missense
Exon 3 of 10NP_001121116.1P14867
GABRA1
NM_000806.5
c.85C>Tp.Pro29Ser
missense
Exon 4 of 11NP_000797.2A8K177
GABRA1
NM_001127643.2
c.85C>Tp.Pro29Ser
missense
Exon 4 of 11NP_001121115.1P14867

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA1
ENST00000393943.10
TSL:1 MANE Select
c.85C>Tp.Pro29Ser
missense
Exon 3 of 10ENSP00000377517.4P14867
GABRA1
ENST00000023897.10
TSL:1
c.85C>Tp.Pro29Ser
missense
Exon 4 of 11ENSP00000023897.6P14867
GABRA1
ENST00000428797.7
TSL:1
c.85C>Tp.Pro29Ser
missense
Exon 4 of 11ENSP00000393097.2P14867

Frequencies

GnomAD3 genomes
AF:
0.000126
AC:
19
AN:
151270
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000461
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000280
AC:
7
AN:
249980
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.000433
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000837
AC:
12
AN:
1432980
Hom.:
0
Cov.:
27
AF XY:
0.00000700
AC XY:
5
AN XY:
714792
show subpopulations
African (AFR)
AF:
0.000274
AC:
9
AN:
32806
American (AMR)
AF:
0.00
AC:
0
AN:
44610
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25860
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39490
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85484
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53332
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5708
European-Non Finnish (NFE)
AF:
9.21e-7
AC:
1
AN:
1086228
Other (OTH)
AF:
0.0000336
AC:
2
AN:
59462
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000126
AC:
19
AN:
151388
Hom.:
0
Cov.:
32
AF XY:
0.0000676
AC XY:
5
AN XY:
73942
show subpopulations
African (AFR)
AF:
0.000459
AC:
19
AN:
41350
American (AMR)
AF:
0.00
AC:
0
AN:
15186
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3458
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10500
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67630
Other (OTH)
AF:
0.00
AC:
0
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000156
Hom.:
0
Bravo
AF:
0.000208
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000412
AC:
5

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Developmental and epileptic encephalopathy, 19 (2)
-
1
1
not provided (2)
-
-
1
Idiopathic generalized epilepsy;C1970160:Epilepsy, childhood absence 4;C4013473:Epilepsy, idiopathic generalized, susceptibility to, 13 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
13
DANN
Benign
0.45
DEOGEN2
Benign
0.22
T
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.61
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.059
D
MetaRNN
Benign
0.048
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.55
N
PhyloP100
4.1
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.45
N
REVEL
Benign
0.11
Sift
Benign
0.37
T
Sift4G
Benign
0.74
T
Polyphen
0.020
B
Vest4
0.075
MVP
0.65
MPC
1.1
ClinPred
0.0099
T
GERP RS
2.2
Varity_R
0.037
gMVP
0.44
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143815396; hg19: chr5-161281174; API